Tag Archives: Accelerated

COVID-19 Has Accelerated Consumers’ Interest in Healthy Home Tech

One in two U.S. adults say their concerns about personal health and wellness increased in the past year: in particular, stress and anxiety, and sleep and eating habits. Despite spending more time at home due to the COVID-19 pandemic, few people believe they live in a “healthy home.” The vast majority of consumers are concerned… Read More »

Viltepso (viltolarsen) Injection Granted Accelerated Approval for Rare Duchenne Muscular Dystrophy Mutation

News Consumer News Viltepso (viltolarsen) Injection Granted Accelerated Approval for Rare Duchenne Muscular Dystrophy Mutation THURSDAY, Aug. 13, 2020 — Accelerated approval has been granted to Viltepso (viltolarsen) injection for treatment of patients with Duchenne muscular dystrophy (DMD) and a mutation of the DMD gene amenable to exon 53 skipping, the U.S. Food and Drug… Read More »

Blancco Technology Group and Partner Data Agility Group Announce Accelerated Growth of Erasure as a Service Sales Opportunities

Increasing focus on consumer data privacy and corporate social responsibility initiatives lead to higher demand for secure data sanitization Austin, TEXAS – April 9, 2020 – Blancco Technology Group (LON: BLTG), the industry standard in data erasure and mobile device diagnostics, today announced that due to its close partnership with Data Agility Group (DAG), which… Read More »

FDA Grants Genentech’s Polivy (polatuzumab vedotin-piiq) Accelerated Approval for Adults With Previously Treated Aggressive Lymphoma

Print this page South San Francisco, CA — June 10, 2019 — Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Polivy (polatuzumab vedotin-piiq) in combination with bendamustine plus Rituxan (rituximab) (BR) for the treatment of adults with relapsed or refractory (R/R)… Read More »